Cholinergic rebound in neuroleptic withdrawal syndromes.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000150:complications*
D014150:Antipsychotic Agents; D010276:Parasympatholytics